Butz, H.; Vereczki, V.; Budai, B.; Rubovszky, G.; Gyebrovszki, R.; Vida, R.; Szőcs, E.; Gerecs, B.; Kohánka, A.; Tóth, E.;
et al. Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies. Int. J. Mol. Sci. 2024, 25, 11813.
https://doi.org/10.3390/ijms252111813
AMA Style
Butz H, Vereczki V, Budai B, Rubovszky G, Gyebrovszki R, Vida R, Szőcs E, Gerecs B, Kohánka A, Tóth E,
et al. Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies. International Journal of Molecular Sciences. 2024; 25(21):11813.
https://doi.org/10.3390/ijms252111813
Chicago/Turabian Style
Butz, Henriett, Viktória Vereczki, Barna Budai, Gábor Rubovszky, Rebeka Gyebrovszki, Ramóna Vida, Erika Szőcs, Bence Gerecs, Andrea Kohánka, Erika Tóth,
and et al. 2024. "Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies" International Journal of Molecular Sciences 25, no. 21: 11813.
https://doi.org/10.3390/ijms252111813
APA Style
Butz, H., Vereczki, V., Budai, B., Rubovszky, G., Gyebrovszki, R., Vida, R., Szőcs, E., Gerecs, B., Kohánka, A., Tóth, E., Likó, I., Kacskovics, I., & Patócs, A.
(2024). Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies. International Journal of Molecular Sciences, 25(21), 11813.
https://doi.org/10.3390/ijms252111813